Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate

Metabolism: Clinical and Experimental
Dong-Sung LeeDae Ho Lee

Abstract

Studies have shown that dipeptidyl peptidase-4 (DPP-4) inhibitors have anti-inflammatory effects. Soluble DPP-4 (sDPP-4) has been considered as an adipokine of which actions need to be further characterized. We investigated the pro-inflammatory actions of sDPP-4 and the anti-inflammatory effects of DPP-4 inhibition, using vildagliptin, as an enzymatic inhibitor, and mannose-6-phosphate (M6P) as a competitive binding inhibitor. In lipopolysaccharide (LPS)-stimulated RAW264.7 cells, vildagliptin suppressed the increased expression of inducible nitric oxide synthase (iNOS) and phosphorylated JNK (pJNK), activation of the NF-κB pathway, and the resultant NO and proinflammatory cytokine production. Although sDPP-4 alone did not affect the protein level of iNOS or pJNK or the production of NO in RAW264.7 cells, it did amplify iNOS expression, NO responses, and proinflammatory cytokine production in LPS-stimulated RAW264 cells. As a probable mechanism, we found that sDPP-4 caused dose-dependent increases in the expression levels of toll-like receptor 4 (TLR4) and TLR2 in RAW264.7 cells, and that these alterations were inhibited by vildagliptin, M6P, or bisindolylmaleimide II, a protein kinase C inhibitor. Either vildagliptin or M6P su...Continue Reading

References

Jul 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·H IkushimaC Morimoto
Sep 14, 2001·Scandinavian Journal of Immunology·M D GorrellG W McCaughan
Mar 22, 2003·European Journal of Cell Biology·Emil Boonacker, Cornelis J F Van Noorden
Dec 4, 2003·The International Journal of Biochemistry & Cell Biology·Ezra AksoyFabienne Willems
Feb 9, 2007·The Journal of Biological Chemistry·Kei OhnumaChikao Morimoto
Oct 2, 2007·Diabetes Research and Clinical Practice·Aine M McKillopPeter R Flatt
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Kei OhnumaChikao Morimoto
Jun 30, 2012·The Journal of Clinical Endocrinology and Metabolism·Antoine MakdissiParesh Dandona
Mar 30, 2013·The Journal of Clinical Endocrinology and Metabolism·Sang Ah LeeDae Ho Lee
Nov 5, 2013·The Journal of Clinical Endocrinology and Metabolism·Ishwarlal JialalSridevi Devaraj
Jun 16, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Annayya R AroorVincent G DeMarco
Jul 9, 2014·Diabetes & Metabolism Journal·Eun Yeong ChoeEun Seok Kang
Aug 21, 2014·BioMed Research International·Na-Hyung KimDae Ho Lee
Sep 13, 2014·Endocrine Reviews·Erin E Mulvihill, Daniel J Drucker

❮ Previous
Next ❯

Citations

Aug 27, 2016·Clinical Reviews in Allergy & Immunology·Juan J Nieto-FontarigoFrancisco J Salgado
Mar 29, 2020·International Journal of Molecular Sciences·Michał WicińskiBartosz Malinowski
Apr 5, 2017·Bio-medical Materials and Engineering·Qi SunXiaohua He
Sep 27, 2019·Therapeutic Advances in Chronic Disease·Shian-Ren LinChing-Feng Weng
Nov 9, 2018·Oxidative Medicine and Cellular Longevity·Iman O Sherif, Nora H Al-Shaalan
Oct 22, 2020·The Journal of Clinical Endocrinology and Metabolism·Nathalie RohmannMatthias Laudes
Mar 17, 2021·Biochemical Pharmacology·R YazbeckC A Abbott
Jun 14, 2020·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Laongdao ThongnakAnusorn Lungkaphin
Jul 11, 2021·Cell Biology International·Vijayendran GovindasamySoon-Keng Cheong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here